General Information of This Antibody-drug Conjugate (ID: DRG0OWCGF)
ADC Name
AB1380049-SG3932 (DAR4)
Synonyms
AB1380049-SG3932
   Click to Show/Hide
Organization
ASTRAZENECA AB
Drug Status
Investigative
Drug-to-Antibody Ratio
4
Antibody Name
AB1380049
 Antibody Info 
Antigen Name
Folate receptor alpha (FOLR1)
 Antigen Info 
Payload Name
(4-NH2)-Exatecan
 Payload Info 
Payload Target
DNA topoisomerase I (TOP1)
 Target Info 
Linker Name
SG3932 Linker
 Linker Info 
Conjugate Type
Random conjugation through reduced inter-chain cysteines.
Combination Type
SG3932
2027 Update
General Information of The ADMET Data Related to This ADC
Absorption
Click To Hide/Show 2 Absorption Data Related to This Level
Standard Type Value Units Description Reference
Maximum Observed Concentration (Cmax) 121 ug/mL
Human FcRn Tg32 mice (n=3 per group) were dosed intravenously (bolus) with the DAR4 or DAR8 ADCs formed from AB1370049 and SG3932 (5 mg/kg).
[1]
Area Under the Concentration-Time Curve (AUC) 504 ug·day/mL
Human FcRn Tg32 mice (n=3 per group) were dosed intravenously (bolus) with the DAR4 or DAR8 ADCs formed from AB1370049 and SG3932 (5 mg/kg).
[1]
Distribution
Click To Hide/Show 1 Distribution Data Related to This Level
Standard Type Value Units Description Reference
Volume of Distribution (Vd) 126 ml/kg
Human FcRn Tg32 mice (n=3 per group) were dosed intravenously (bolus) with the DAR4 or DAR8 ADCs formed from AB1370049 and SG3932 (5 mg/kg).
[1]
Excretion
Click To Hide/Show 2 Excretion Data Related to This Level
Standard Type Value Units Description Reference
Clearance (CL) 7.2 ml/kg/days
Human FcRn Tg32 mice (n=3 per group) were dosed intravenously (bolus) with the DAR4 or DAR8 ADCs formed from AB1370049 and SG3932 (5 mg/kg).
[1]
Elimination Half-Life (t1/2) 12.2 days
Human FcRn Tg32 mice (n=3 per group) were dosed intravenously (bolus) with the DAR4 or DAR8 ADCs formed from AB1370049 and SG3932 (5 mg/kg).
[1]
References
Ref 1 Binding molecules against FR alpha